Northern Trust Corp Purchases 24,088 Shares of Monogram Orthopaedics, Inc. (NASDAQ:MGRM)

Northern Trust Corp lifted its stake in Monogram Orthopaedics, Inc. (NASDAQ:MGRM) by 110.6% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 45,873 shares of the company’s stock after acquiring an additional 24,088 shares during the period. Northern Trust Corp owned approximately 0.13% of Monogram Orthopaedics worth $109,000 at the end of the most recent reporting period.

Other large investors have also recently made changes to their positions in the company. Wells Fargo & Company MN boosted its holdings in shares of Monogram Orthopaedics by 286.6% in the fourth quarter. Wells Fargo & Company MN now owns 11,597 shares of the company’s stock worth $27,000 after acquiring an additional 8,597 shares during the period. Orion Portfolio Solutions LLC purchased a new stake in shares of Monogram Orthopaedics in the fourth quarter worth $31,000. Commonwealth Equity Services LLC raised its position in shares of Monogram Orthopaedics by 21.5% in the fourth quarter. Commonwealth Equity Services LLC now owns 41,628 shares of the company’s stock worth $99,000 after buying an additional 7,366 shares in the last quarter. Finally, Geode Capital Management LLC raised its position in shares of Monogram Orthopaedics by 7.7% in the fourth quarter. Geode Capital Management LLC now owns 226,378 shares of the company’s stock worth $537,000 after buying an additional 16,234 shares in the last quarter. 0.45% of the stock is owned by institutional investors.

Monogram Orthopaedics Stock Up 1.2%

NASDAQ MGRM opened at $2.44 on Wednesday. The stock’s 50-day simple moving average is $2.67 and its two-hundred day simple moving average is $2.58. Monogram Orthopaedics, Inc. has a twelve month low of $1.92 and a twelve month high of $4.21. The company has a market capitalization of $87.08 million, a price-to-earnings ratio of -5.19 and a beta of 0.74.

Monogram Orthopaedics (NASDAQ:MGRM) last released its quarterly earnings results on Wednesday, May 14th. The company reported ($0.10) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.12) by $0.02. On average, equities analysts expect that Monogram Orthopaedics, Inc. will post -0.49 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently issued reports on the company. Roth Capital set a $5.40 price objective on Monogram Orthopaedics in a research report on Tuesday, March 18th. Roth Mkm increased their price objective on Monogram Orthopaedics from $4.00 to $5.40 and gave the stock a “buy” rating in a research report on Tuesday, March 18th.

Monogram Orthopaedics Profile

Monogram Orthopaedics, Inc focuses on developing a product solution architecture to enable patient-optimized orthopaedic implants. The company intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation for use in reconstructive joint replacement procedures.